CERS logo

Combined Holdings of CERS in All ARK ETFs

Cerus Corporation

CERS, or Cerus Corporation, specializes in developing and commercializing innovative blood transfusion technologies designed to enhance the safety of blood transfusions by inactivating pathogens in blood components. The company generates revenue through the sale and distribution of its INTERCEPT Blood System, particularly in markets requiring advanced blood safety solutions, such as Europe and the United States.

Trades of CERS in All Ark ETFs

The ten most recent trades of Cerus Corporation in all the Ark ETFs ETF.View all trades

Date
Direction
Market Value
% of Position
% of ETF
Oct 30, 2024Buy$277,6422.25%0.02%
Oct 30, 2024Buy$1,303,5686.88%0.02%
Oct 29, 2024Buy$91,4190.74%0.01%
Oct 29, 2024Buy$424,4312.28%0.01%
Oct 28, 2024Buy$385,8782.10%0.01%
Oct 28, 2024Buy$82,0700.67%0.01%
Oct 25, 2024Buy$229,9281.98%0.02%
Oct 25, 2024Buy$1,076,9646.48%0.02%
Oct 24, 2024Buy$92,4090.81%0.01%
Oct 24, 2024Buy$418,7802.62%0.01%